USPTO serial 88391059
INITIAL STATE (OIL SEPRATE FROM WATER) SHAKING/MIXING MIXED STATE (CLOUDY, OIL MIXED WITH WATER) SETTLED STATE (OIL SEPARATED FROM WATER)
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BEN, LINDSEY HEATHER
- Law office
- TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with INITIAL STATE (OIL SEPRATE FROM WATER) SHAKING/MIXING MIXED STATE (CLOUDY, OIL MIXED WITH WATER) SETTLED STATE (OIL SEPARATED FROM WATER)?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Fragrances; Fragrances and perfumery; Body spray used as a personal deodorant and as fragrance; Pet fragrances | PARTIALLY PAID | Dec 7, 2017 |
| 005 | Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents for epidermis; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for skin care; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of worms in pets; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for treating respiratory diseases; Pharmaceutical skin lotions; Pharmaceuticals for the treatment of erectile dysfunction; Anti-epileptic pharmaceutical preparations; Antibacterial pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents in the form of a coating for agents in solution that facilitate the delivery of a wide range of pharmaceuticals; Homeopathic pharmaceuticals for use in the treatment of integumentary conditions; Homeopathic pharmaceuticals for use in the treatment of musculoskeletal conditions; Homeopathic pharmaceuticals for use in the treatment of immune conditions; Homeopathic pharmaceuticals for use in the treatment of neurologic conditions; Homeopathic pharmaceuticals for use in the treatment of digestive conditions; Homeopathic pharmaceuticals for use in the treatment of endocrine conditions; Homeopathic pharmaceuticals for use in the treatment of bacterial infections; Homeopathic pharmaceuticals for use in the treatment of fungal infections | PARTIALLY PAID | Dec 7, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cologne.Dog, Inc.
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named INITIAL STATE (OIL SEPRATE FROM WATER) SHAKING/MIXING MIXED STATE (CLOUDY, OIL MIXED WITH WATER) SETTLED STATE (OIL SEPARATED FROM WATER)
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 21, 2020 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 21, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 9, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 9, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 9, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 8, 2020 | RFTP | REMOVED FROM TEAS PLUS | — |
| Apr 1, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 26, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 19, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| May 17, 2019 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| May 16, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 22, 2019 | NWAP | NEW APPLICATION ENTERED | — |